DiaMedica Therapeutics, Inc. (DMAC)
8.255
+0.24
(+2.93%)
USD |
NASDAQ |
Nov 20, 16:00
8.255
0.00 (0.00%)
After-Hours: 16:05
DiaMedica Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | -277.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.13K% |
| Nektar Therapeutics | -592.9% |
| Fortress Biotech, Inc. | -43.08% |
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -90.62% |
| Return on Assets | -79.62% |
| Return on Invested Capital | -90.19% |
| Return on Net Operating Assets | -12.78K% |